2.Enhancement of Immunogenicity of the Inefficient Antigen Through DNA Vaccine-based Epitope Modification.
Soong Hwa JANG ; Mi Jin KIM ; Yong Suk JANG
Korean Journal of Immunology 2000;22(3):111-116
No abstract available.
DNA*
3.Comparative Study in DNA-mediated Vaccination Efficaency Among the Plasmids with Different Promoters.
Sun Hwa CHANG ; Koo Nam YANG ; Yong Suk JANG
Korean Journal of Immunology 1998;20(4):375-379
Plasmid vectors with either RSV or CMV promoter are frequently used for DNA- mediated immunization due to the availability in commercial. Consequently, influence of the vector constituents, such as promoter, enhancer and transcription termination signal etc. on vaccination efficiency is not studied extensively. As an initial attempt to develop an efficient vector system for DNA-rnediated immunization, influence of promoter for antigen gene expression on vaccination efficiency has been analyzed. Initially, plasmids with either B-actin or muscle creatine kinase (MCK) promoter were constructed from the plasmid with prototype CMV promoter. In addition, ovalbumin (OVA) antigen gene has been cloned into each vectors to generate the plasmid vectors with different promoters for induction of the anti-OVA immune responses. Antigen protein expression in antigen gene transfected mouse muscle myoblast cells showed that the level from MCK promoter containing plasmid was slightly higher than those from either CMV or B-actin promoter containing plasmids. Also, the same plasmid turned out to be slightly more efficient than other plasmids in antibody imrnune response induction in vivo, when they were applied both through intramuscularly and intradermally. These results suggest that the commonly used CMV promoter containing plasmid vector could be further modified to develop an efficient vector for DNA-mediated immunization.
Animals
;
Clone Cells
;
Creatine Kinase, MM Form
;
Gene Expression
;
Immunization
;
Mice
;
Myoblasts
;
Ovalbumin
;
Plasmids*
;
Vaccination*
4.Trends of US Hospitalist and Suggestions for Introduction of Korean Hospitalist.
Sung In JANG ; Suk Yong JANG ; Eun Cheol PARK
Korean Journal of Medicine 2015;89(1):1-5
A gap in the number of physicians caring for inpatients is expected in 2014 based on the restricted working hours for Korean medical residents. One potential solution is the use of hospitalists. The US hospitalist movement has proliferated due to high-quality care and economics. This movement has brought positive changes including a shorter length of hospital stay, increased quality of care, and greater patient satisfaction. Because the Korean government controls all suppliers and maintains a low financial compensation level for universal coverage, hospitals do not have the financial resources to introduce hospitalists. Therefore, in contrast to the US, the use of hospitalists must be developed as a cost-compensated system in Korea. Institutional strategies must be introduced to develop a hospitalist system in Korea. A hospitalist system in Korea would be distinct from that in the US. Further studies and specific strategies are needed that consider Korea's circumstances to effectively introduce a hospitalist system.
Compensation and Redress
;
Hospital Medicine
;
Hospitalists*
;
Humans
;
Inpatients
;
Korea
;
Length of Stay
;
Patient Satisfaction
;
Universal Coverage
5.The Property of p53 Gene in Cell Lines of Squamous Cell Carcinoma.
Yu JIN ; Yong Suk MOON ; Hyo Soon JEONG ; Sung Ik JANG ; In Jang CHOI
Korean Journal of Anatomy 2004;37(3):293-299
The mutation of p53 tumor suppressor gene is the most common genetic variation of primary malignant tumors. The occurrence, progression and reaction for medical management of cancers can be different according to the characteristics of p53 gene, even if they are same kinds of malignant tumors. In this study, the property of p53 gene in 4 kinds of squamous cell carcinoma cell lines were investigated by using immunocytochemistry, PCR-SSCP, sequencing and Western blot methods. As a result, p53 mutation detected in 3 kinds of squamous cell carcinoma cell lines. Namely, it is found that T in codon 176 changed to A, and G in codon 281 changed to A in KUMA3 cell lines; CC in codon 241 changed to TT in KUMA4 cell lines; G in codon 266 changed to T in KUMA6 cell lines. In single nucleotide polymorphism of codon 72 of p53 gene, the genetic variations are Arg/Pro heterozygote in KUMA3 and KUMA4 cell lines; Arg/Arg homozygote in KUMA5 cell lines; Pro/Pro homozygote in KUMA6 cell lines. These results will provide useful data for p53 gene researches of various squamous cell carcinomas.
Blotting, Western
;
Carcinoma, Squamous Cell*
;
Cell Line*
;
Codon
;
Genes, p53*
;
Genes, Tumor Suppressor
;
Genetic Variation
;
Heterozygote
;
Homozygote
;
Immunohistochemistry
;
Polymorphism, Single Nucleotide
6.A clinical study on the postpartum depression.
Yong Jin NA ; Byung Min LEE ; Jin Suk JANG ; Ook Hwan CHOI ; Won Whe KIM
Korean Journal of Obstetrics and Gynecology 1993;36(10):3539-3549
No abstract available.
Depression, Postpartum*
;
Female
;
Postpartum Period*
7.Incarceration of the Gravid Uterus with Myoma: Report of One Patient Managed with Uterine Reduction.
Tae Gee JANG ; Min Hwan KO ; Tae Hyun LEE ; Eun Jee LEE ; Suk Yong WON
Korean Journal of Obstetrics and Gynecology 2000;43(11):2059-2061
Incarceration of the gravid uterus is a rare but serious complication of pregnancy. Reported is the case of a gravid 2, para 0, abortus 1 with known uterine subserosal myoma(5.3 x5.5cm sized) 26-year-old woman presented with acute dysuria and urinary retention. The patient was 14 weeks and 3 days pregnant and presented several week history of urinary frequency and sensation of incomplete bladder emptying. Examination revealed a retroflexed uterus with cervical opening pointing toward the anterior abdominal wall. An ultrasound revealed a thin, elongated maternal bladder and a uterus incarcerated between the sacral promontary and the pubis. The incarceration was successfully reduced by tenaculum traction of the cervical posterior lip without surgical intervention and had a normal infant of appropriate weight at term.
Abdominal Wall
;
Adult
;
Dysuria
;
Female
;
Humans
;
Infant
;
Leiomyoma
;
Lip
;
Myoma*
;
Pregnancy
;
Sensation
;
Traction
;
Ultrasonography
;
Urinary Bladder
;
Urinary Retention
;
Uterine Retroversion
;
Uterus*
8.The Structural Properties of Israeli Carp ( Cyprinus carpio L. ) Immunoglobulin.
Sang Hoon CHOI ; Jong Kyu WOO ; Yong Suk JANG ; Chan Ho OH
Korean Journal of Immunology 1999;21(1):85-92
Serum immunoglobulins from Israeli carp (I. carp) were purified using affinity chromatography. Fish were immunized with purified mouse IgG, and the specific fish antibodies purified from the immune serum on a mouse IgG-immobilized agarose gel. Rabbit anti-carp Ig (Raclg) antibodies were produced following hyperimmunization with mlgG specific I. Carp Ab. SDS-PAGE analysis under reducing condition showed that I. carp Ig (clg) were composed of two u-like heavy chains with about 82 and 50 kD, respectively and one light chain with about 25 kD. On immunoblotting analysis, however, Raclg failed to react with light chain. When both protein A and protein G purified normal clg were compared with mlgG specific clg, no significant structural differences among them were observed. To investigate if there is any homology between other fish Ig molecules, cross-reactivity of Raclg against Ig molecules from 6 different fish sera and mouse control serum was checked on immunoblotting analysis. As a result, Raclg responded to only carp and tilapia Ig molecules, indicating that both tilapia and carp are very closely associated, especially, in the genetic basis of immunoglobulin structure. In flow cytometry study, Raclg appeared to recognize 45.8% of carp Ig+, 14.5% of catfish Ig+ and <5% of tilapia Ig+ cells. The result suggest the heterogeniety between receptor immunoglobulins on B-like lymphocytes and soluble immunoglobulins in serum. It is crucial to obtain pure fish immunoglobulins to produce reagent antibodies as tools for the study of their specific immune response.
Animals
;
Antibodies
;
Carps*
;
Catfishes
;
Chromatography, Affinity
;
Electrophoresis, Polyacrylamide Gel
;
Flow Cytometry
;
Immunoblotting
;
Immunoglobulin G
;
Immunoglobulins*
;
Lymphocytes
;
Mice
;
Sepharose
;
Staphylococcal Protein A
;
Tilapia
9.Iliac Vein Compression Syndrome: 4 Case
Suk Il MOON ; Yong Gui KIM ; In Sung MOON ; Jang Sang PARK ; Yong Bok KOH
Journal of the Korean Society for Vascular Surgery 1998;14(2):275-280
Iliac vein compression syndrome is a rare clinical condition in which left common iliac vein is anatomically compressed between right common iliac artery and the fifth lumbar vertebrae or pelvic brim. Patients usually have marked edema of the left leg. Although the actual incidence is unknown, this syndrome most affects women in the second to fourth decade of life. We report 4 cases of iliac compression syndrome treated by surgical intervention during the last fifteen-year period. Among them, two women have suffered from chronic intermittent swelling and pain of left leg, and two men had acute or subacute symptoms. The fibrous web in the entrance of left iliac vein into vena cava existed in one case. Including this one, two were treated by transposition of iliac artery or vein with thrombectomy. One was decompressed the arterial compression by mobilization or adhesiolysis of the surrounding vessles with thrombectomy. To the last one in which the distal common iliac vein was compressed by tortous dilated left internal iliac artery, transsection and ligation of the internal iliac artery was performed. All patients have experienced improved left leg condition after operation. except the last one in which suffered from thrombosis of left popliteal vein after the iliac decompression.
Decompression
;
Edema
;
Female
;
Humans
;
Iliac Artery
;
Iliac Vein
;
Incidence
;
Leg
;
Ligation
;
Lumbar Vertebrae
;
Male
;
May-Thurner Syndrome
;
Popliteal Vein
;
Thrombectomy
;
Thrombosis
;
Veins
10.The development of mucosal vaccines for both mucosal and systemic immune induction and the roles played by adjuvants.
Clinical and Experimental Vaccine Research 2017;6(1):15-21
Vaccination is the most successful immunological practice that improves the quality of human life and health. Vaccine materials include antigens of pathogens and adjuvants potentiating the effectiveness of vaccination. Vaccines are categorized using various criteria, including the vaccination material used and the method of administration. Traditionally, vaccines have been injected via needles. However, given that most pathogens first infect mucosal surfaces, there is increasing interest in the establishment of protective mucosal immunity, achieved by vaccination via mucosal routes. This review summarizes recent developments in mucosal vaccines and their associated adjuvants.
Humans
;
Immunity, Mucosal
;
Methods
;
Needles
;
Vaccination
;
Vaccines*